Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Viruses|March 30, 2023
HIV-1 Non-Group M Strains and ARTElodie Alessandri-Gradt, Alice Moisan, Jean-Christophe PlantierScientific Reports|January 19, 2024
In vitro replicative potential of an HIV-1/MO intergroup recombinant virus compared to HIV-1/M and HIV-1/O parental virusesAlice Moisan, Fabienne Tombette, Manon Vautrin, et al.Viruses|May 27, 2023
Evaluation of Analytical and Clinical Performance and Usefulness in a Real-Life Hospital Setting of Two in-House Real-Time RT-PCR Assays to Track SARS-CoV-2 Variants of ConcernAlice Moisan, Anaïs Soares, Fabienne De Oliveira, et al.AIDS (London, England)|April 6, 2019
Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patientsElodie Alessandri-Gradt, Guillemette Unal, Marie Leoz, et al.Journal of Clinical Microbiology|February 26, 2016
A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV VariantsPierre Cappy, Fabienne De Oliveira, Marie Gueudin, et al.The Journal of Antimicrobial Chemotherapy|July 23, 2018
Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavirElodie Alessandri-Gradt, Charlotte Charpentier, Marie Leoz, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2021
Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O VariantsElodie Alessandri-Gradt, Guillemette Unal, Adeline Baron, et al.Virologie (Montrouge, France)|November 3, 2025
[Genetic evolution between HIV-1 groups M and O: HIV-1/MO recombinant forms]Alice Moisan, Fabienne Tombette, Jean-Christophe PlantierJournal of Acquired Immune Deficiency Syndromes (1999)|March 24, 2016
Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 VariantsMarie Gueudin, Adeline Baron, Elodie Alessandri-Gradt, et al.Journal of Medical Virology|April 11, 2026
HIV-1 Non Group-M Phenotypic Susceptibility to IbalizumabLucie Poisson, Quentin Le Hingrat, Fanny Lermechain, et al.Pageof 16